ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

US, China and other rich nations chase COVID-19 vaccine paydays

Developing countries at the back of the queue face costly vaccine imports

Wealthy countries are buying up massive doses of expensive and so far unproven candidate vaccines against COVID-19 in the hope of containing domestic outbreaks.    © Reuters

TOKYO -- As COVID-19 continues its devastating global rampage, countries are competing fiercely to secure vaccine supplies once they become available.

Rich nations are investing heavily to ensure they receive millions of doses, leaving developing countries in their wake.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more